baber/WOPTO huggingface dataset:
Patent AU-622812-B2 (AU)
Title: Reflective polymeric body
Inventor: WHEATLEY JOHN A
IPC: B32B7/023
Filed: 1990-06-19
Granted: 1992-04-16
Abstract: A multilayered reflective body comprises alternating layers of at least first and second polymeric materials of which layers a substantial majority have an optical thickness of not more than 0.09 micrometers or not less than 0.45 micrometers, and adjacent layers of said first and second polymeric materials differ from each other in refractive index by at least 0.03. A sufficient number of layers are present that essentially no perceived iridescence is reflected and, usually, 30 percent of non-absorbed incident light is reflected. The reflective body may be fabricated into sheets, mirrors, noncorroding metallic appearing articles and parts, reflectors, and reflective lenses.
Patent AU-625506-B2 (AU)
Title: Method of connecting pipes of plastics material of a double pipe system and a pipe connection made by the method
Inventor: WERMELINGER JORG
IPC: F16L47/02
Filed: 1990-07-05
Granted: 1992-07-16
Abstract: The inner pipes (2a, 2b) of a double pipe system are fixedly connected to a collar (3) by welding or bonding. In order to retain the inner pipes (2a, 2b) by means of clamping jaws (4a, 4b) when producing the collar connection, the outer pipes (1a, 1b) are constructed shorter, at least by the thickness of the two clamping jaws (4a, 4b). In order to bridge this gap, an expandable intermediate ring (9, 9a) is inserted during the connection of the outer pipes (1a, 1b) by means of an electrically welded sleeve (7). 
<IMAGE>
Patent AU-532634-B2 (AU)
Title: Thiazolyl derivatives
Inventor: ROANTREE MICHAEL LAURENCE
IPC: C07D417/12
Filed: 1980-10-24
Granted: 1983-10-06
Abstract: The present invention provides compounds of formula (I): <CHEM> and pharmaceutically acceptable salts thereof, which have histamine H2-antagonist activity. In formula (I) Z is sulphur or methylene and R<1> is hydrogen, C1-4alkyl, optionally substituted phenyl or phenyl (C1-4 alkyl) (the substituents being one or more C1-4 alkyl, or C1-4 alkoxy groups or halogen atoms or a methylenedioxy group), or optionally substituted furanyl-, thienyl, or pyridyl- (C1-4 alkyl) (the substituents being one or more C1-4 alkyl or C1-4 alkoxy groups); and R<2> is hydrogen, C1-4 alkyl or benzyl. One particular compound of formula (I) is 2-[2-(2-guanidino-4-thiazolylmethylthio)] ethylamino-3-nitro pyrrole.
Patent AU-600681-B2 (AU)
Title: Biocompatible microporous polymeric materials and methods of making same
Inventor: GILDING D KEITH
IPC: A61F2/06
Filed: 1986-10-17
Granted: 1990-08-23
Abstract: A microporous biocompatible material is formed by pre­paring a segmented polyether urethane urea solution containing 25% ± 1.5% solids dissolved in a solvent. The solution has sufficient viscosity to be preshaped and formed into the desired thickness of the finished article, then immediately immersed into a precipitation bath in which the solvent in the solution is miscible for a time interval sufficient to cause the solution to set up into an opaque elastomeric article. The article is immediately removed from the bath, any excess solvent extracted and then dried at a temperature on the order of 35°C. to 70°C. followed by heat treating by annealing for approximately sixty minutes at a temperature at 100°C. to 130°C. The void volume of the membrane solution is controlled to within the 50% to 80% range and the pore size from ca <0.1 to several mms. as well as the shape of the pores and solid structures between them, thereby enabling close control over the characteristics and structure of the material as well as other variations in structural characteristics and porosity across the thickness of the material according to its intended application and use.
Patent AU-705817-B2 (AU)
Title: Physically active antimicrobial gel for cosmetic products
Inventor: GREFF DANIEL
IPC: A61K8/02
Filed: 1996-08-02
Granted: 1999-06-03
Abstract: PCT No. PCT/FR96/01229 Sec. 371 Date Feb. 4, 1998 Sec. 102(e) Date Feb. 4, 1998 PCT Filed Aug. 2, 1996 PCT Pub. No. WO97/05856 PCT Pub. Date Feb. 20, 1997A gel, in a proportion of 1 to 20% of the finished product, contains at least one polyol, one (meth)acrylic acid polymer and one fluidification solvent of general formula (1): R1-O-(R2-O-R2)n,-OR3, wherein R1 is a hydrogen atom or a straight or branched C1-C5 alkyl chain, R2 is a straight or branched C1-C5 alkyl chain, R3 is a hydrogen atom or a straight or branched C1-C5 alkyl chain, and n is an integer of 1 to 200,000.
Patent AU-700190-B2 (AU)
Title: Continuously operating infusion device and method
Inventor: NEFTEL FREDERIC
IPC: A61M5/142
Filed: 1996-08-20
Granted: 1998-12-24
Abstract: PCT No. PCT/FR96/01297 Sec. 371 Date Feb. 24, 1998 Sec. 102(e) Date Feb. 24, 1998 PCT Filed Aug. 20, 1996 PCT Pub. No. WO97/07842 PCT Pub. Date Mar. 6, 1997The invention relates to injection apparatus that is capable of operating continuously. According to the invention, the apparatus comprises two independent injection bottles (12) of at least one liquid that is to be injected into a patient via a tube, each of the bottles including means (51) for detecting that injection of the liquid contained in the bottle has terminated, which means control means (53) for interrupting the flow of liquid. The apparatus comprises upstream injection apparatus (10) having two feeder tubes (50) connected to respective bottles (12), and downstream injection apparatus (70) with pump means (72, 84) for pumping the liquid and connected firstly to the patient via a downstream tube (78) and secondly to coupling means (54). An application is performing perfusion prior to radiological examination using an X-ray or an NMR scanner.
Patent AU-652734-B2 (AU)
Title: Optical inspection method and apparatus
Inventor: SMITH MARTIN PHILLIP
IPC: G01N3/00
Filed: 1991-01-25
Granted: 1994-09-08
Abstract: PCT No. PCT/GB91/00109 Sec. 371 Date Jun. 15, 1992 Sec. 102(e) Date Jun. 15, 1992 PCT Filed Jan. 25, 1991 PCT Pub. No. WO91/11699 PCT Pub. Date Aug. 8, 1991.Apparatus for optical inspection of particulate material such as diamond abrasive comprises a body (1), an open sample container (25) which can rise and fall in the body, a reference member (71) above the container, mounted in a removable compaction head (9) of which the height relative to the body is fixed, and an optical inspection head (11) mountable on the body in place of composition head. The container is raised into contact with the reference member so that the surface of the sample is levelled and placed at a predetermined height. The compaction head is then removed and replaced by the optical inspection head. Consequently, the sample surface is always presented to the optical inspection head in a predetermined relationship and in particular at a predetermined height.
Patent AU-706310-B2 (AU)
Title: Improved film facestock and display products
Inventor: TUNG HARVEY C
IPC: C08J5/18
Filed: 1996-08-12
Granted: 1999-06-17
Abstract: A deformable label comprising a printable film facestock having at least one layer containing incompatible polymers. The printable film facestock exhibits significantly reduced die-face buildup during extrusion of the printable film facestock when compared to the die-face buildup exhibited by film facestock of the prior art. The present invention provides for monolayer film facestock containing incompatible polymers and colorants. The present invention also allows printable film facestock to be produced in a more cost-effective manner.
Patent AU-631095-B2 (AU)
Title: Magnetic document validator employing remanence and saturation measurements
IPC: G07D7/04
Filed: 1990-12-24
Granted: 1992-11-12
Abstract: A method of and apparatus for determining the genuineness of a document such as a currency note printed at least in part with magnetizable ink in which there is produced a first signal as a measure of the saturation magnetization of a portion of the document printed with the ink and a second signal as a measure of the remanent magnetization of said portion and in which the ratio of the second signal to the first signal is determined as a measure of genuineness of the document.
Patent AU-642973-B2 (AU)
Title: Labelstock for in-mold labeling
Inventor: TUNG HARVEY C
IPC: B32B7/02
Filed: 1991-01-10
Granted: 1993-11-04
Abstract: Wholly extrudable polymeric labelstock for in-mold labeling purposes which is characterized by a tensile ultimate elongation per ASTM D-882 of at least 10 percent in one or both of the machine and transverse directions, and which contains a sufficient amount of one or more slip additives to prevent a significant degree of edge-welding between adjacent stacked sheets of the labelstock on a high type die cutter in an in-mold labeling process, and the in-mold labeling process employing such labelstock.
Patent AU-638114-B2 (AU)
Title: Heat resistant propylene polymer compositions
IPC: C08L23/00
Filed: 1991-03-20
Granted: 1993-06-17
Abstract: A compsn. comprises (a) a resin, consisting of (i) a polyphenylene ether resin, (ii) a styrene resfn, or (iii) mixts. of (i) and (ii); (b) a styrenic grafted propylene polymer; (c) monoalkenyl aromatic hydrocarbon-conjugated diene block copolymers, hydrogenated prods. or mixts.; and (d) a propylene polymer. Amts. of (a), (b), (c) and (d) are 10-65 (pref. 20-60) wt.%, 5-30 (pref. 10-25) wt.%, 1-15 (pref. 4-12) wt.% and 1-70 (pref. 5-55) wt.% respectively. (iii) has 2-98 wt.% of (ii) based on the total amt. of (i) and (ii). The styrenic monomer content of (b) is 5-70 (pref. 10-55) wt.%. The total amt. of (a) + (b) + (c) + (d) is 100%.
Patent AU-725283-B2 (AU)
Title: Bioadhesive pharmaceutical composition for the controlled release of active principles
Inventor: RAULT ISABELLE
IPC: C08F218/08
Filed: 1996-12-23
Granted: 2000-10-12
Abstract: Bioadhesive pharmaceutical composition for the controlled release of active agents in the mouth or via a mucous membrane, comprises one or more vinyl acetate/polyvinylpyrrolidone copolymers (A). The composition is preferably in the form of a matrix and bioadhesion is ensured for up to 24 hours.
Patent AU-631987-B2 (AU)
Title: All season type tire tread
IPC: B60C11/113
Filed: 1991-04-29
Granted: 1992-12-10
Abstract: An all season type tire tread (11) comprises a plurality of laterally extending grooves (36) having curved portions adjacent to each lateral edge (TE1, TE2) of the tread, said curved portions extending in circumferentially opposite directions. Axially spaced zig-zag shaped grooves (4-8) extend circumferentially around the tread, every fourth leg of a zig-zag groove being coincident with a portion of a laterally extending groove (36). Two legs adjacent to said fourth leg connect the laterally extending grooves to short semi-blind grooves (19) having their central portion coincident with every other fourth leg of the zig-zag shaped groove. The various grooves cooperate to define block elements (20-25), arranged in circumferential rows (30-35) and having the shape of an "S" or of a "Z". The blocks can include a plurality of slots (50-53) and humps (29) can be located between neighboring blocks. <IMAGE>
Patent AU-604044-B2 (AU)
Title: Glass pane having a profile strand
Inventor: KUNERT HEINZ
IPC: E06B3/56
Filed: 1987-08-13
Granted: 1990-12-06
Abstract: A motor vehicle window (1) intended to be glued to the fixing flange (3) of the window frame of a motor vehicle body is provided along its edge with a profiled bead (4) made from a hardened adhesive material. This profiled bead (4) forms an intermediate element which is no longer plastically deformable between the window (1) and the bead of adhesive (12). The bead (12) has, in cross-section, substantially the shape of a U and has anchoring projections (9, 10). The anchoring projections (9, 10) determine a shape-matching and force-transfer join between the bead of adhesive (12) and the profiled bead (4). They can, furthermore, serve to fix, by clamping, various fishplates, attachments or profiled strips. 
<IMAGE>
Patent AU-740161-B2 (AU)
Title: Treating metal surfaces to enhance bio-compatibility and/or physical characteristics
Inventor: TAKTAK YOUSEF SAMIH
IPC: A61F2/04
Filed: 1998-06-03
Granted: 2001-11-01
Abstract: A metal, glass or ceramics surface is treated to enhance its compatibility with biological material such as blood or blood related products. Treatment involves covalently bonding to the surface by means of a catalyst functional molecules each of has at least one alkoxysilane group which can form at least one first covalent bond by reaction with the oxide or hydroxide of said surface and at least one other group which can participate in free-radical polymerisation. Free-radical polymerisation from said functional molecules is then effected to build bio-compatible and/or hydrophilic polymer chains. The compatibility of the metal surface with biological material may be further improved by bonding bio-active molecules, such as heparin or heparin derived molecules to the polymer chains. Suitable metal surfaces are those of medical devices such as heat exchangers, coronary and peripheral stents and guide wires used in angioplasty. In the case of a stent, restenosis may be inhibited by incorporating into the coating a radio-labelled compound, foe example radio-labelled heparin and/or by incorporating a compound that inhibits cell proliferation e.g. mitoxantrone.
Patent AU-743733-B2 (AU)
Title: Reception method and receiver
Inventor: HOTTINEN ARI
IPC: H04B1/707
Filed: 1998-06-23
Granted: 2002-01-31
Abstract: The invention relates to a reception method and a receiver in a system comprising in each cell a base station communicating with terminals located in its area. A received signal comprises a sum signal of signals originating from several transmitters. The receiver comprises means for performing interference elimination and a simultaneous multi-user detection to the signal and means for searching signal parameters. In order to reduce the required computational capacity, the receiver further comprises means for removing the effect of the signals of the known users from the receives sum signal, and means for estimating the parameters of the unknown signals from a narrowband residual signal.
Patent AU-646483-B2 (AU)
Title: Optical disc recording apparatus
Inventor: MAEDA YASUAKI
IPC: G11B7/004
Filed: 1991-08-20
Granted: 1994-02-24
Abstract: The appts. records on an optical disc (2) having a memory (14) for storing input digital data compressed from a continuous signal. A signal encoder (15) arranges data from memory (14). The arrangement is multiple clusters at an interval of a set number of sectors annexing to each a linking sector. The cluster data is interleaved for the recording circuit (3, 4). An abnormality detection circuit (30) acts through a controller (7) to inhibit recording upon detection of abnormality. This performs a read out control of the memory.
Patent AU-600061-B2 (AU)
Title: Ceric oxide catalyst and method of manufacture
Inventor: DAVID CLAIRE
IPC: C01F17/235
Filed: 1987-12-18
Granted: 1990-08-02
Abstract: Morphologically improved ceric oxide particulates have a BET specific surface, measured after calcination at a temperature of from 350 DEG to 450 DEG  C., of at least 100 m2/g, a total pore volume of at least 0.3 cm3/g, and the pores of which having a mean diameter larger than 50  ANGSTROM . The improved ceric oxide particulates are prepared by reacting a cerium salt with a strong base in the presence of carboxylate ions, or a cerium carboxylate with a strong base; separating the precipitate of true cerium hydroxide thus produced; and washing, heat-treating, and calcining such precipitate.
Patent AU-754640-B2 (AU)
Title: Delayed progression to AIDS by a missense allele of the CCR2 gene
Inventor: DEAN MICHAEL
IPC: C12Q1/68
Filed: 1998-08-10
Granted: 2002-11-21
Abstract: The present invention relates to a CCR2 deletion mutant, designated "CCR2-64I." CCR2 is a C-C chemokine receptor and has been implicated as a co-receptor for HIV-1. It has been discovered that the presence of the CCR2-64I allele correlates with a postponement of AIDS outcomes, and that infected individuals who have the CCR2-64I allele are at a reduced risk for progression from HIV-1 infection to the development of clinical AIDS and death. Isolated nucleic acid molecule encoding CCR2-64I and the establishment of cell lines that express CCR2-64I provides valuable tools for continuing research on HIV infection. Diagnostic methods for analysis of the allelic frequency of CCR2 wild-type and 64I genes are provided. In addition, antibodies which bind to CCR2-64I, CCR2-64I variants, and CCR2 binding agents represent potential anti-HIV agents.
Patent DE-1902339-B2 (DE)
Title: Temp. compensated transistor oscillator - has auxiliary transistor generating change in collector current to adjust control potentiometer
IPC: H03B5/04
Filed: 1969-01-17
Abstract: The frequency of operation of transistor oscillators operating in the lower micro-wave region is stabilised against temp. effects by an additional compensating transistor which reacts to the error between reference and actual frequency. The main oscillator consists of an npn type transistor stage (T1) with a coupled capacitive band fitter (L1,L2,C1,C2,C3). The auxiliary transistor (T2) for compensation is thermally coupled in that it is subjected to the same heat transfer as the main oscillator. The auxiliary has a base voltage divider (TR1, TR2). The collector is coupled to a potentiometer (R4) adjusted by the increased collector current in the event of a temperature increase.
Patent DE-2002353-B2 (DE)
Title: Failure detection for single channel binary control - uses logic system connecting voltage divider and trigger circuit with alarm
IPC: G08C25/00
Filed: 1970-01-15
Abstract: The failure detection and recognition circuit is used for failure signals in a single channel binary control system. It employs both AND-gates (7.1, 7.2) and OR gates (10.1, 10.2) connected to the inputs and the output of the control system (5). The two AND-gates (.1, 7.2) are connected via an OR-gate (8) with an alarm device (9). The two OR gates (10.1, 10.2) are connected via AND gates (11.1, 11.2) and a timing element (12) to a further alarm (13). A voltage divider (15) followed by a trigger circuit (16) is coupled to the output of the timing element (12) and the OR gate (8) to which the two AND gates (7.1, 7.2) are connected.
Patent DE-2134831-B2 (DE)
Title: Frequency doubler for square wave pulses - has input capacitor and two opposing decoupling diodes connected to differential amplifier
IPC: H03B19/16
Filed: 1971-07-13
Abstract: The frequency doubler, for squarewave pulse trans, has the pulses applied over a capacitor (C) and two oppositely- poled diodes to the two inputs of a differential amplifier (DV). The anode of one diode is connected to the junction between a first series pair of biasing resistors, and the cathode of the other diode is connected to the junction between a second series pair of biasing resistors. The frequency doubled squarewave is taken from the amplifier's output. The two decoupling diodes are poled so that negative pulses reach the amplifier's positive input, and positive pulses its negative input.
Patent JP-S6360036-B2 (JP)
IPC: C07J17/00
Filed: 1982-01-29
Abstract: This invention relates to novel 3,20-dioxo-1,4-pregnadiene-17 alpha -ol 17-aromatic heterocyclic carboxylates, to pharmaceutical formulations thereof, and their use in the treatment and control of inflammatory conditions.
Patent JP-H0642404-B2 (JP)
Inventor: IRIE TAKASHI
IPC: H01T4/04
Filed: 1989-01-27
Abstract: PURPOSE:To enhance a discharge characteristic by a method wherein an electrode plate is made larger than a size of an outside diameter of an arrester element, its edge-face shape is formed to be an arc shape or a spherical surface shape and a plane part of a prescribed length from an outer periphery face of the arrester element is formed with reference to a part to an outer periphery of the electrode plate. CONSTITUTION:When an overvoltage of a lightning surge is applied to a lightning arrester 1, this electric current is guided as follows: an upper-part hat-shaped electrode 8   an upper- part conductive piece 13   an upper-part sealing electrode 4   an intermediate electrode 6 a soft conductive foil film 21   an arrester element 3   a lower-part sealing electrode 5   a lower-part conductive piece 13   a lower-part hat-shaped electrode 9. During this process, the arrester element 3 built in a wall tube insulator 2 quickly reduces its resistance value by its characteristic and passes a large electric current caused by the lightning surge. The arrester element 3 immediately restores its resistance value with reference to an operating voltage following the lightning surge and restores its insulation; accordingly, a follow-current discharge is not caused, and a line is restored to a normal state. A plane part 6b at a prescribed distance L from an outer periphery face 3b of the arrester element 3 is formed at a part to an outer periphery of the intermediate electrode 6; accordingly, lines of electric force H continued from the inside to the outside of the arrester element 3 are continued smoothly to a spherical surface part 6a; it is possible to relax that an electric field is concentrated in a part near the plane part 6b. Thereby, it is possible to suppress a sudden rise and a disorder of the line of electric force stretched from the inside to the outside of the lightning element and to make the discharge characteristic good.
Patent JP-H075534-B2 (JP)
IPC: C07C231/02
Filed: 1988-02-04
Abstract: There are described optically active derivatives of (R) 5-pentylamino-5-oxopentanoic acid and their pharmaceutically acceptable salts, having antagonistic activity towards cholecystokinin, and with the formula: <CHEM> in which R1 is selected from the groups 2-naphthyl, 3,4-dichlorobenzoyl and 3,4-dimethylbenzoyl and R2 is a pentyl group or an alkoxyalkyl group with 4 carbon atoms, and in which the substituents on the central chiral group (marked with an asterisk in Formula (I)) have the R (rectus) conformation.
Patent JP-H0636760-B2 (JP)
IPC: C12Q1/68
Filed: 1991-01-28
Abstract: The present invention involves methods of improving LCR and PCR amplification schemes by modifying at least one probe/primer end so that the probability of the probe/primer contributing to spurious signal development is greatly reduced. Only after specific hybridization of the modified probe/primer with true target, are the modified ends "corrected" in a target dependent fashion to allow participation of the probe/primer in the enzymatic assembly reaction. Specific modifications depend on whether the assembly is done by ligation (as in LCR) or by extension/elongation (as in PCR). <IMAGE>
Patent JP-H0830504-B2 (JP)
IPC: F16H39/14
Filed: 1987-02-12
Abstract: Device wherein the co-operation of a rotatable shaft and the displacement of a hydraulic medium forms a variable transmission unit or a pump, said device comprising an ingoing (driving) shaft having a widened part/rotor and an outgoing (driven) shaft co-axial with the ingoing shaft, the widened part of the.ingoing shaft being provided with a number of cylindrical bores, substantially parallel to its centre line, each bore containing a plunger which can reciprocate in said bore, said outgoing shaft being provided with a plate (mirror plate) obliquely arranged under an angle α with respect to the axis of the shaft for co-operating with protruding end(s) of the plunger(s) such that upon rotation of the rotor or the outgoing shaft the plunger(s) reciprocate in its (their) bores, each bore presenting in its wall a radially directed channel to establish a connection between the bore(s) and a circuit containing a hydraulic medium.